UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 282

Sortiert nach

Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid

Journal of investigative dermatology, 2016-11, Vol.136 (11), p.2201-2210

2016

Volltextzugriff (PDF)

Bullous pemphigoid exacerbated by nivolumab and temporally rescued with therapeutic plasma exchange

Journal of dermatology, 2024-05, Vol.51 (5), p.e149-e150

2024

Volltextzugriff (PDF)

Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid

Journal of dermatology, 2018-05, Vol.45 (5), p.596-599

2018

Volltextzugriff (PDF)

Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein

Journal of dermatological science, 2024-04, Vol.114 (1), p.44-51

2024

Volltextzugriff (PDF)

Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid

Acta dermato-venereologica, 2023-03, Vol.103, p.adv00888-adv00888

2023

Volltextzugriff (PDF)

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1

Cancer immunology research, 2016-05, Vol.4 (5), p.383-389

2016

Volltextzugriff (PDF)

Missed drug-induced bullous pemphigoid leads to longer immunosuppression than recognized cases: A 9-year retrospective review

Journal of the American Academy of Dermatology, 2020-05, Vol.82 (5), p.1255-1258

2020

Volltextzugriff (PDF)

Nodular formation in anti‐laminin γ1 pemphigoid

Journal of dermatology, 2020-03, Vol.47 (3), p.e80-e82

2020

Volltextzugriff (PDF)

Bullous pemphigoid associated with chronic hepatitis C virus infection in a hepatitis B virus endemic area: A case report

Medicine (Baltimore), 2018-04, Vol.97 (15), p.e0377

2018

Volltextzugriff (PDF)

Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies

Melanoma research, 2016-08, Vol.26 (4), p.413-416

2016

Volltextzugriff (PDF)

B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid

Scientific reports, 2019-03, Vol.9 (1), p.3525-3525, Article 3525

2019

Volltextzugriff (PDF)

Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid

JAMA dermatology (Chicago, Ill.), 2019-02, Vol.155 (2), p.166

2019

Volltextzugriff (PDF)

A new clinical variant of acquired reactive perforating dermatosis‐like bullous pemphigoid

British journal of dermatology (1951), 2019-01, Vol.180 (1), p.231-232

2019

Volltextzugriff (PDF)

Mucous Membrane Pemphigoid: A Case Report with Oral and Ocular Presentation

The journal of contemporary dental practice, 2022-07, Vol.23 (7), p.755-759

Fageeh, Hammam Ibrahim

2022

Volltextzugriff (PDF)

Grover disease and bullous pemphigoid: a clinicopathological study of six cases

Clinical and experimental dermatology, 2019-07, Vol.44 (5), p.524-527

2019

Volltextzugriff (PDF)

Clinical and immunological features and outcome of anti-p200 pemphigoid

British journal of dermatology (1951), 2016-10, Vol.175 (4), p.776-781

2016

Volltextzugriff (PDF)

Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study

JAMA dermatology (Chicago, Ill.), 2014-01, Vol.150 (1), p.25

2014

Volltextzugriff (PDF)

Dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid in a patient with acquired reactive perforating collagenosis

Journal of dermatology, 2018-05, Vol.45 (5), p.600-602

2018

Volltextzugriff (PDF)

Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology

Journal of diabetes investigation, 2019-09, Vol.10 (5), p.1168-1170

2019

Volltextzugriff (PDF)

Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature

Melanoma research, 2018-12, Vol.28 (6), p.491-501

2018

Volltextzugriff (PDF)

Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab

Journal of allergy and clinical immunology, 2009-03, Vol.123 (3), p.704-705

2009

Volltextzugriff (PDF)

Case of papuloerythroderma of Ofuji‐like eruption during the course of bullous pemphigoid

Journal of dermatology, 2018-03, Vol.45 (3), p.e63-e64

2018

Volltextzugriff (PDF)

Bullous Pemphigoid Masquerading as Erythrodermic Psoriasis

West African journal of medicine, 2022-12, Vol.39 (12), p.1319

2022

Volltextzugriff (PDF)

Case of bullous pemphigoid associated with teneligliptin accompanied by severe mucous membrane involvement

Journal of dermatology, 2018-07, Vol.45 (7), p.e205-e206

2018

Volltextzugriff (PDF)

1 – 25 von 282

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

ThemaMiddle Aged

ThemaAged

ThemaPemphigoid, Bullous - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)

Publikationsform

Artikel
(279)
magazinearticle
(3)

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(282)
Science & Technology
(204)
Life Sciences & Biomedicine
(202)
Dermatology
(177)
Female
(161)
Male
(161)
Pemphigoid, Bullous - Immunology
(95)
Pemphigoid, Bullous - Drug Therapy
(88)
Biological And Medical Sciences
(87)
Medical Sciences
(86)
Skin - Pathology
(67)
Bullous Diseases Of The Skin
(63)
Pemphigoid, Bullous - Complications
(63)
Aged, 80 And Over
(60)
Pemphigoid, Bullous - Diagnosis
(57)
Immunoglobulin G - Analysis
(52)
Diagnosis, Differential
(50)
Bullous Pemphigoid
(45)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid

Bullous pemphigoid exacerbated by nivolumab and temporally rescued with therapeutic plasma exchange

Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid

Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein

Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1

Missed drug-induced bullous pemphigoid leads to longer immunosuppression than recognized cases: A 9-year retrospective review

Nodular formation in anti‐laminin γ1 pemphigoid

Bullous pemphigoid associated with chronic hepatitis C virus infection in a hepatitis B virus endemic area: A case report

Bullous pemphigoid, an autoantibody-mediated disease, is a novel immune-related adverse event in patients treated with anti-programmed cell death 1 antibodies

B-cell depletion induces a shift in self antigen specific B-cell repertoire and cytokine pattern in patients with bullous pemphigoid

Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid

A new clinical variant of acquired reactive perforating dermatosis‐like bullous pemphigoid

Mucous Membrane Pemphigoid: A Case Report with Oral and Ocular Presentation

Grover disease and bullous pemphigoid: a clinicopathological study of six cases

Characterization of the skin microbiota in bullous pemphigoid patients and controls reveals novel microbial indicators of disease

Clinical and immunological features and outcome of anti-p200 pemphigoid

Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study

Dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid in a patient with acquired reactive perforating collagenosis

Bullous pemphigoid with dipeptidyl peptidase‐4 inhibitors: Clinical features and pathophysiology

Anti-programmed cell death-1 therapy-associated bullous disorders: a systematic review of the literature

Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab

Case of papuloerythroderma of Ofuji‐like eruption during the course of bullous pemphigoid

Bullous Pemphigoid Masquerading as Erythrodermic Psoriasis

Case of bullous pemphigoid associated with teneligliptin accompanied by severe mucous membrane involvement

Aktive Filter

Suchergebnisse filtern